Athanor Capital, LP Eli Lilly & CO Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $535,668 - $708,818	-4,106 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $600,379 - $694,447	4,106 New	4,106 $608,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $809,540 - $1 Million	-6,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $727,056 - $900,524	6,800 New	6,800 $894,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $14.3 Million - $16.7 Million	-129,404 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $14.4 Million - $17 Million	129,404 New	129,404 $16.8 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.